Maria V. Corrias

Genoa, 16147, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications

Predictive Microbial Markers Distinguish Responders and Non-Responders to Adalimumab: A Step Toward Precision Medicine in Ulcerative Colitis.

Predictive Microbial Markers Distinguish Responders and Non-Responders to Adalimumab: A Step Toward Precision Medicine in Ulcerative Colitis.

Journal: Microorganisms
Published: June 23, 2025

In Infants with Neuroblastoma Standard Therapy Only Partially Reverts the Fecal Microbiome Dysbiosis Present at Diagnosis.

In Infants with Neuroblastoma Standard Therapy Only Partially Reverts the Fecal Microbiome Dysbiosis Present at Diagnosis.

Journal: Microorganisms
Published: February 21, 2025

Detection of plasma circulating GD2 ganglioside in patients with neuroblastoma and age-matched healthy children. Diagnostic and prognostic evaluation.

Detection of plasma circulating GD2 ganglioside in patients with neuroblastoma and age-matched healthy children. Diagnostic and prognostic evaluation.

Journal: The oncologist
Published: August 09, 2024

Immunomodulatory properties of extracellular vesicles isolated from bone marrow of patients with neuroblastoma: role of PD-L1 and HLA-G.

Immunomodulatory properties of extracellular vesicles isolated from bone marrow of patients with neuroblastoma: role of PD-L1 and HLA-G.

Journal: Frontiers in immunology
Published: July 24, 2024

Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing.

Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing.

Journal: HLA
Published: January 15, 2024

From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models.

From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models.

Journal: Journal of translational medicine
Published: October 25, 2023

Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma.

Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma.

Journal: Journal for immunotherapy of cancer
Published: August 27, 2023

Neuroblastoma is associated with alterations in gut microbiome composition subsequent to maternal microbial seeding.

Neuroblastoma is associated with alterations in gut microbiome composition subsequent to maternal microbial seeding.

Journal: EBioMedicine
Published: July 12, 2023

Maternal and food microbial sources shape the infant microbiome of a rural Ethiopian population.

Maternal and food microbial sources shape the infant microbiome of a rural Ethiopian population.

Journal: Current biology : CB
Published: June 17, 2022

Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature.

Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature.

Journal: Pediatric hematology and oncology
Published: February 10, 2022

Nucleolin expression has prognostic value in neuroblastoma patients.

Nucleolin expression has prognostic value in neuroblastoma patients.

Journal: EBioMedicine
Published: January 24, 2022

A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma.

A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma.

Journal: Cancers
Published: October 01, 2021
Showing 1-12 of 50

Last Updated: 09/26/2026